97% of men survive malignant melanoma for at least one year, and this is predicted to fall to 88% surviving for five years or more, as shown by
Malignant Melanoma (C43), Age-Standardised One-, Five- and Ten-Year Age-Standardised Net Survival, Adults (Aged 15-99), England and Wales, 2010-2011
|1-Year Survival (%)||5-Year Survival (%)||10-Year Survival (%)|
95% LCL and 95% UCL are the 95% lower and upper
Five- and ten-year survival is predicted using an excess hazard statistical model
Malignant melanoma survival falls only slightly beyond five years after diagnosis for men, and does not continue to fall beyond five years for women, which means most patients can be considered cured after five years. 86% of men and 92% of women are predicted to survive their disease for ten years or more, as shown by age-standardised net survival for patients diagnosed with malignant melanoma during 2010-2011 in England and Wales. Out of 20 common cancers in England and Wales, ten-year survival for malignant melanoma ranks 2nd highest overall.
Malignant Melanoma (C43), Net Survival up to Ten Years after Diagnosis, Adults (Aged 15-99), England and Wales, 2010-2011
Survival for malignant melanoma is reported in Scotland and Northern Ireland,[2,3] though it is difficult to make survival comparisons between countries due to different methodologies and criteria for including patients in analyses.
About this data
Data is for: England and Wales, 2010-2011, ICD-10 C43